Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo
nivolumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma after prior fluoropyrimidine and platinum chemotherapy.
LAMPGEN ANALYSIS
Why it matters
Added single-agent checkpoint blockade after standard chemotherapy for squamous esophageal cancer.
What research teams should watch
Verify squamous histology and both prior chemotherapy components; monitor swallowing symptoms and nutrition.
PRIMARY RECORDS